Vanderbilt Vaccine Center (VVC) Archive — Page 12 of 13
-
November 1, 2012
Genomic research gains ad-“vantage” with new resources
Vanderbilt University Medical Center has stepped up its support of research aimed at cracking the mysteries of the genome, the master DNA code. -
July 19, 2012
Long antibodies better against HIV
Understanding how antibodies with long “loops” form may be important for HIV vaccine development. -
April 27, 2012
Dengue antibodies give vaccine leads
New information may help speed development of a vaccine or treatment for dengue fever. -
April 12, 2012
Targeting post-transplant diabetes
Targeting diabetes that develops after a stem cell transplant may help moderate graft-vs.-host disease, an adverse effect of the procedure, and improve outcomes. -
February 15, 2012
On the tail of RSV infection mechanism
New details about the life cycle of respiratory syncytial virus (RSV) could aid the development of therapies to combat this leading cause of serious illness in infants and the elderly. -
January 20, 2012
Digestive disease research bolstered by grant renewal
The Vanderbilt Digestive Disease Research Center celebrates its 10th anniversary this year with a second five-year renewal of its federal research grant. -
October 7, 2011
Diversity key in antibody repertoire
Antibodies to the 2009 H1N1 influenza strain reveal new insights into how antibody diversity forms and functions, with possible implications for designing flu vaccines.